We propose that the MLH1 polymorphism is an important risk factor for development of MLH1 methylation but only in certain cellular environments such as sessile serrated adenomas and BRAF mutant colorectal cancers arising from sessile serrated adenomas. This evidence concerns the gene BRAF and adenoma.